Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.53T
24h Vol:
$9.62B
Dominance:
MSFT:5.17%
Stocklytics Platform
BETA
Instrument logo  GILD

Gilead Sciences Inc

GILD
73 / 100
S&P500
$72.95arrow_drop_down-0.81%-$0.60

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Gilead Sciences Inc (GILD) Stocklytics Forecast

Gilead Sciences Inc (GILD) is a leading biopharmaceutical company that focuses on the development and commercialization of innovative medicines. The company has a strong track record of bringing breakthrough treatments to patients, particularly in the areas of HIV/AIDS, liver diseases, and viral hepatitis. Gilead's stock price has been subject to fluctuations over the years, influenced by various factors including regulatory approvals, clinical trial results, and market dynamics. As of now, the stock price of Gilead Sciences Inc (GILD) reflects an optimistic outlook, with analysts predicting a positive trend in the coming years.

Looking into the future, Gilead Sciences Inc (GILD) is expected to experience continued growth and success. The company has a robust pipeline of potential new therapies, which are in various stages of development and clinical trials. This positions Gilead to address unmet medical needs and capitalize on market opportunities. With its strong financial position and commitment to research and development, Gilead is well-equipped to drive innovation and deliver meaningful solutions to patients. Analysts have set a price target for Gilead Sciences Inc (GILD) for the year 2023, reflecting confidence in the company's future prospects.

add Gilead Sciences Inc to watchlist

Keep an eye on Gilead Sciences Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is the analyst price prediction for Gilead Sciences Inc (GILD) stock?

Currently, there are no available analyst price predictions for Gilead Sciences Inc (GILD). This absence of data could be due to various factors such as the lack of recent analyst reviews or updates.

question_mark
What are the analyst ratings for Gilead Sciences Inc (GILD) stock?

The analyst ratings for Gilead Sciences Inc (GILD) are distributed as follows: 13 analysts recommend buying, 15 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 28 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering Gilead Sciences Inc.

question_mark
What is the AI price prediction for Gilead Sciences Inc (GILD) stock?

The AI price prediction model, leveraging machine-learning techniques, forecasts that Gilead Sciences Inc (GILD) stock could reach $73.17 by 2024 Feb 29. This prediction indicates a potential price change of 0.31%. The forecast has a lifetime of 30 days, culminating on the target date provided. The prediction was made on 2024 Feb 01.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.